Animal studies showed that myocardial gene transfer of vascular endothelial growth factor (VEGF) or fibroblast growth factor (FGF) can improve cardiac angiogenesis2,3 or connexin-43 can limit atrial fibrillation and ventricular tachycardia4. Here, VEGFA is linked to atrial fibrillation.